These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 12560429

  • 21. A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma.
    Ang MK, Poon D, Foo KF, Chung YF, Chow P, Wan WK, Thng CH, Ooi L.
    Hematol Oncol Stem Cell Ther; 2008; 1(3):159-65. PubMed ID: 20063546
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
    Yamashita T, Arai K, Sunagozaka H, Ueda T, Terashima T, Yamashita T, Mizukoshi E, Sakai A, Nakamoto Y, Honda M, Kaneko S.
    Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
    [Abstract] [Full Text] [Related]

  • 25. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
    Nagano H, Sakon M, Monden M.
    Nihon Rinsho; 2002 Nov; 60(11):2237-44. PubMed ID: 12440136
    [Abstract] [Full Text] [Related]

  • 26. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus.
    Wadler S, Haynes H, Beitler JJ, Hu X, Fell S, Camacho M, Levine B, Wiernik PH.
    Cancer; 1996 Jul 01; 78(1):30-4. PubMed ID: 8646722
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
    Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    Int J Clin Oncol; 2011 Jun 01; 16(3):221-9. PubMed ID: 21132451
    [Abstract] [Full Text] [Related]

  • 30. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY, Cheong JY, Cho SW, Sim SJ, Kim JS, Choi SJ, Choi JW, Kwon HC, Lee KM, Kim JK, Won JH, Yoo BM, Lee KJ, Hahm KB, Kim JH.
    Korean J Hepatol; 2006 Mar 01; 12(1):65-73. PubMed ID: 16565607
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H, Miyamoto A, Wada H, Ota H, Marubashi S, Takeda Y, Dono K, Umeshita K, Sakon M, Monden M.
    Cancer; 2007 Dec 01; 110(11):2493-501. PubMed ID: 17941012
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
    Lu YS, Hsu C, Li CC, Kuo SH, Yeh KH, Yang CH, Hsu CH, Wu CY, Cheng AL.
    Hepatogastroenterology; 2004 Dec 01; 51(57):815-9. PubMed ID: 15143923
    [Abstract] [Full Text] [Related]

  • 35. [A report of two cases--two patients of the extremely advanced hepatocellular carcinoma have responded completely for a long time after a combination therapy consisting of arterial chemotherapy and injection of interferon-alpha].
    Iijima S, Kikkawa N, Kurokawa E, Yamamoto H, Kato T, Tsujie M, Ohshima S, Hayashi T, Naoi Y, Hatanaka T, Danno M, Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Monden M.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1669-72. PubMed ID: 14619490
    [Abstract] [Full Text] [Related]

  • 36. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J, Shen WL, Yang SH.
    Hepatobiliary Pancreat Dis Int; 2006 May 01; 5(2):224-7. PubMed ID: 16698580
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T, Mimura T, Tutui N.
    J Hepatobiliary Pancreat Surg; 2005 May 01; 12(3):249-53. PubMed ID: 15995815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.